Serina Therapeutics, Inc.
Q1 2025 13F Holders
Symbol
SER
CUSIP
81751A108
Type
Equity
Class
COM SHS
Num filings
26
Total reported value, excl. options
$1.90 M
Compare 2025 Q1 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type